Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    14645636 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Experimental: Cabazitaxel 15mg/m2;   Drug: Experimental: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
2 Completed Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
Condition: Head and Neck Cancer
Interventions: Drug: chemotherapy;   Drug: cisplatin;   Drug: fluorouracil;   Procedure: conventional surgery;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy

Indicates status has not been verified in more than two years